vs
HIVE Digital Technologies Ltd.（HIVE）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
HIVE Digital Technologies Ltd.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$93.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -98.1%，领先482.1%），HIVE Digital Technologies Ltd.同比增速更快（218.6% vs 21.2%），过去两年HIVE Digital Technologies Ltd.的营收复合增速更高（102.2% vs 53.7%）
该企业是一家数字化转型与信息技术服务公司，总部位于宾夕法尼亚州匹兹堡，业务覆盖北美、中东、亚洲以及日本地区，为各行各业的企业客户提供专业的IT相关服务支持。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HIVE vs RIGL — 直观对比
营收规模更大
HIVE
是对方的1.3倍
$69.8M
营收增速更快
HIVE
高出197.4%
21.2%
净利率更高
RIGL
高出482.1%
-98.1%
两年增速更快
HIVE
近两年复合增速
53.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.1M | $69.8M |
| 净利润 | $-91.3M | $268.1M |
| 毛利率 | -27.1% | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | -98.1% | 384.0% |
| 营收同比 | 218.6% | 21.2% |
| 净利润同比 | -234.0% | 1769.2% |
| 每股收益（稀释后） | $-0.38 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HIVERIGL
| Q4 25 | $93.1M | $69.8M | ||
| Q3 25 | $87.3M | $69.5M | ||
| Q2 25 | $45.6M | $101.7M | ||
| Q1 25 | — | $53.3M | ||
| Q4 24 | $29.2M | $57.6M | ||
| Q3 24 | $22.6M | $55.3M | ||
| Q2 24 | $32.2M | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润HIVERIGL
| Q4 25 | $-91.3M | $268.1M | ||
| Q3 25 | $-15.8M | $27.9M | ||
| Q2 25 | $35.0M | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $68.2M | $14.3M | ||
| Q3 24 | $80.0K | $12.4M | ||
| Q2 24 | $-18.3M | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率HIVERIGL
| Q4 25 | -27.1% | 91.5% | ||
| Q3 25 | 4.7% | 93.2% | ||
| Q2 25 | -13.6% | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | -43.7% | 89.9% | ||
| Q3 24 | -66.1% | 85.5% | ||
| Q2 24 | -7.4% | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HIVERIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率HIVERIGL
| Q4 25 | -98.1% | 384.0% | ||
| Q3 25 | -18.1% | 40.2% | ||
| Q2 25 | 76.8% | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | 233.2% | 24.9% | ||
| Q3 24 | 0.4% | 22.5% | ||
| Q2 24 | -56.7% | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益（稀释后）HIVERIGL
| Q4 25 | $-0.38 | $14.11 | ||
| Q3 25 | $-0.07 | $1.46 | ||
| Q2 25 | $0.18 | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | $0.52 | $0.82 | ||
| Q3 24 | $0.00 | $0.70 | ||
| Q2 24 | $-0.17 | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $559.3M | $391.5M |
| 总资产 | $624.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HIVERIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | $40.5M | $77.3M | ||
| Q3 24 | $31.7M | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务HIVERIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HIVERIGL
| Q4 25 | $559.3M | $391.5M | ||
| Q3 25 | $624.6M | $117.6M | ||
| Q2 25 | $560.5M | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | $430.9M | $3.3M | ||
| Q3 24 | $275.5M | $-14.6M | ||
| Q2 24 | $268.6M | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产HIVERIGL
| Q4 25 | $624.0M | $513.6M | ||
| Q3 25 | $693.0M | $242.5M | ||
| Q2 25 | $628.7M | $206.7M | ||
| Q1 25 | — | $176.0M | ||
| Q4 24 | $478.6M | $164.0M | ||
| Q3 24 | $334.7M | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比HIVERIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HIVERIGL
| Q4 25 | $46.0M | $22.0M | ||
| Q3 25 | $-10.6M | $24.0M | ||
| Q2 25 | $10.2M | $30.5M | ||
| Q1 25 | — | $-893.0K | ||
| Q4 24 | $-28.5M | $14.5M | ||
| Q3 24 | $-2.2M | $21.7M | ||
| Q2 24 | $-4.4M | $302.0K | ||
| Q1 24 | — | $-5.0M |
自由现金流HIVERIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-55.5M | — | ||
| Q3 24 | $-34.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率HIVERIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -189.9% | — | ||
| Q3 24 | -153.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度HIVERIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 143.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率HIVERIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 0.29× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | -0.42× | 1.01× | ||
| Q3 24 | -26.94× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
